2016 updated EULAR evidence-based recommendations for the management of gout
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
2016 updated EULAR evidence-based recommendations for the management of gout
Authors
Keywords
-
Journal
ANNALS OF THE RHEUMATIC DISEASES
Volume 76, Issue 1, Pages 29-42
Publisher
BMJ
Online
2016-07-26
DOI
10.1136/annrheumdis-2016-209707
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oral Prednisolone in the Treatment of Acute Gout
- (2016) Timothy Hudson Rainer et al. ANNALS OF INTERNAL MEDICINE
- Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol
- (2016) Fernando Perez-Ruiz et al. ANNALS OF THE RHEUMATIC DISEASES
- Risk of cutaneous adverse events with febuxostat treatment in patients with skin reaction to allopurinol. A retrospective, hospital-based study of 101 patients with consecutive allopurinol and febuxostat treatment
- (2016) Thomas Bardin et al. JOINT BONE SPINE
- Association of Serum Uric Acid and Disease Duration With Frequent Gout Attacks: A Case-Control Study
- (2016) Abhishek Abhishek et al. ARTHRITIS CARE & RESEARCH
- Prevalence of Gout in the Adult Population of France
- (2016) Thomas Bardin et al. ARTHRITIS CARE & RESEARCH
- Weight Loss, Xanthine Oxidase, and Serum Urate Levels: A Prospective Longitudinal Study of Obese Patients
- (2016) Pascal Richette et al. ARTHRITIS CARE & RESEARCH
- Impact of Febuxostat on Renal Function in Gout Patients With Moderate-to-Severe Renal Impairment
- (2016) Kenneth G. Saag et al. Arthritis & Rheumatology
- Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia: A 6-Month, Double-Blind, Randomized, Placebo-Controlled Trial
- (2015) Dipankar Sircar et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Allopurinol and Progression of CKD and Cardiovascular Events: Long-term Follow-up of a Randomized Clinical Trial
- (2015) Marian Goicoechea et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Urate crystal deposition in asymptomatic hyperuricaemia and symptomatic gout: a dual energy CT study
- (2015) Nicola Dalbeth et al. ANNALS OF THE RHEUMATIC DISEASES
- Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study
- (2015) M. M. Givertz et al. CIRCULATION
- Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update
- (2015) Y Saito et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- New medications in development for the treatment of hyperuricemia of gout
- (2015) Cesar Diaz-Torné et al. CURRENT OPINION IN RHEUMATOLOGY
- Allopurinol use and risk of non-fatal acute myocardial infarction
- (2015) Francisco J de Abajo et al. HEART
- Comprehensive dietary education in treated gout patients does not further improve serum urate
- (2015) R. Holland et al. INTERNAL MEDICINE JOURNAL
- Does Starting Allopurinol Prolong Acute Treated Gout? A Randomized Clinical Trial
- (2015) Erica M. Hill et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Hyperuricemia starts at 360 micromoles (6mg/dL)
- (2015) Thomas Bardin JOINT BONE SPINE
- Immunologic basis for allopurinol-induced severe cutaneous adverse reactions: HLA-B*58:01-restricted activation of drug-specific T cells and molecular interaction
- (2015) Chia-Hsien Lin et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Global epidemiology of gout: prevalence, incidence and risk factors
- (2015) Chang-Fu Kuo et al. Nature Reviews Rheumatology
- Plasma uric acid concentrations are reduced by fenofibrate: A systematic review and meta-analysis of randomized placebo-controlled trials
- (2015) Giuseppe Derosa et al. PHARMACOLOGICAL RESEARCH
- Population Pharmacokinetics and Therapeutic Efficacy of Febuxostat in Patients with Severe Renal Impairment
- (2015) Daiki Hira et al. PHARMACOLOGY
- Gout and Risk of Myocardial Infarction: A Systematic Review and Meta-Analysis of Cohort Studies
- (2015) Shuang-Chun Liu et al. PLoS One
- Raising the quality of rheumatology management recommendations: lessons from the EULAR process 10 years after provision of standard operating procedures
- (2015) Alexandra N. Colebatch-Bourn et al. RHEUMATOLOGY
- Cost-Effectiveness Analysis of HLA-B5801 Genotyping in the Treatment of Gout Patients With Chronic Renal Insufficiency in Korea
- (2015) Dong-Jin Park et al. ARTHRITIS CARE & RESEARCH
- Urate lowering therapy to improve renal outcomes in patients with chronic kidney disease: systematic review and meta-analysis
- (2015) Tahir Kanji et al. BMC Nephrology
- Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study
- (2015) Tai-Ming Ko et al. BMJ-British Medical Journal
- Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study
- (2015) Tai-Ming Ko et al. BMJ-British Medical Journal
- Cost-Effectiveness of Allopurinol and Febuxostat for the Management of Gout
- (2014) Eric Jutkowitz et al. ANNALS OF INTERNAL MEDICINE
- Attenuating the mortality risk of high serum uric acid: the role of physical activity underused
- (2014) Jiunn-Horng Chen et al. ANNALS OF THE RHEUMATIC DISEASES
- Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study
- (2014) Chang-Fu Kuo et al. ANNALS OF THE RHEUMATIC DISEASES
- Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: the impact of renal insufficiency, high plasma levels of oxypurinol and granulysin
- (2014) Wen-Hung Chung et al. ANNALS OF THE RHEUMATIC DISEASES
- Impact of allopurinol on risk of myocardial infarction
- (2014) L Grimaldi-Bensouda et al. ANNALS OF THE RHEUMATIC DISEASES
- 2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations
- (2014) Désirée van der Heijde et al. ANNALS OF THE RHEUMATIC DISEASES
- Hyperuricaemia and gout: time for a new staging system?
- (2014) Nicola Dalbeth et al. ANNALS OF THE RHEUMATIC DISEASES
- Increased risk of vascular disease associated with gout: a retrospective, matched cohort study in the UK Clinical Practice Research Datalink
- (2014) Lorna E Clarson et al. ANNALS OF THE RHEUMATIC DISEASES
- Single-Dose, Open-Label Study of the Differences in Pharmacokinetics of Colchicine in Subjects with Renal Impairment, Including End-Stage Renal Disease
- (2014) Suman Wason et al. CLINICAL DRUG INVESTIGATION
- Definition of hyperuricemia and gouty conditions
- (2014) Thomas Bardin et al. CURRENT OPINION IN RHEUMATOLOGY
- Eligibility for and Prescription of Urate-Lowering Treatment in Patients With Incident Gout in England
- (2014) Chang-Fu Kuo et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Oxypurinol Directly and Immediately Activates the Drug-Specific T Cells via the Preferential Use of HLA-B*58:01
- (2014) J. Yun et al. JOURNAL OF IMMUNOLOGY
- Influence of serum uric acid levels on prognosis and survival in amyotrophic lateral sclerosis: a meta-analysis
- (2014) Alon Abraham et al. JOURNAL OF NEUROLOGY
- Rilonacept for Gout Flare Prevention in Patients Receiving Uric Acid-lowering Therapy: Results of RESURGE, a Phase III, International Safety Study
- (2014) J. S. Sundy et al. JOURNAL OF RHEUMATOLOGY
- Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial
- (2014) Ángel Chamorro et al. LANCET NEUROLOGY
- Allopurinol Therapy in Gout Patients Does Not Associate with Beneficial Cardiovascular Outcomes: A Population-Based Matched-Cohort Study
- (2014) Victor C. Kok et al. PLoS One
- Cost-Effectiveness Analysis of HLA-B*5801 Testing in Preventing Allopurinol-Induced SJS/TEN in Thai Population
- (2014) Surasak Saokaew et al. PLoS One
- Emerging Therapies for Gout
- (2014) N. Lawrence Edwards et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Epidemiology of Gout
- (2014) Edward Roddy et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout
- (2014) Peter E Lipsky et al. ARTHRITIS RESEARCH & THERAPY
- Revisiting comorbidities in gout: a cluster analysis
- (2013) Pascal Richette et al. ANNALS OF THE RHEUMATIC DISEASES
- Impact of bariatric surgery on serum urate targets in people with morbid obesity and diabetes: a prospective longitudinal study
- (2013) Nicola Dalbeth et al. ANNALS OF THE RHEUMATIC DISEASES
- Tophaceous gout and high level of hyperuricaemia are both associated with increased risk of mortality in patients with gout
- (2013) Fernando Perez-Ruiz et al. ANNALS OF THE RHEUMATIC DISEASES
- New Therapies for Gout
- (2013) Daria B. Crittenden et al. Annual Review of Medicine
- Allopurinol hypersensitivity is primarily mediated by dose-dependent oxypurinol-specific T cell response
- (2013) J. Yun et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Serum uric acid and metabolic risk
- (2013) P. Richette et al. CURRENT MEDICAL RESEARCH AND OPINION
- Allopurinol Hypersensitivity: A Systematic Review of All Published Cases, 1950–2012
- (2013) Sheena N. Ramasamy et al. DRUG SAFETY
- Efficacy and Tolerability of Probenecid as Urate-lowering Therapy in Gout; Clinical Experience in High-prevalence Population
- (2013) K. Pui et al. JOURNAL OF RHEUMATOLOGY
- Colchicine Treatment for the Prevention of Bare-Metal Stent Restenosis in Diabetic Patients
- (2013) Spyridon Deftereos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis
- (2013) Bhadran Bose et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Independent and conjoint associations of gout and hyperuricaemia with total and cardiovascular mortality
- (2013) A.G. Stack et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Relative and attributable diabetes risk associated with hyperuricemia in US veterans with gout
- (2013) E. Krishnan et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Gout and the Heart
- (2013) Vidula Bhole et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Rilonacept for gout flare prevention during initiation of uric acid-lowering therapy: results from the PRESURGE-2 international, phase 3, randomized, placebo-controlled trial
- (2013) Essack Mitha et al. RHEUMATOLOGY
- Rates of adherence and persistence with allopurinol therapy among gout patients in Israel
- (2013) G. Zandman-Goddard et al. RHEUMATOLOGY
- Health-related quality of life in gout: a systematic review
- (2013) Priyanka Chandratre et al. RHEUMATOLOGY
- Gout as a risk factor for myocardial infarction and stroke in England: evidence from record linkage studies
- (2013) Olena O. Seminog et al. RHEUMATOLOGY
- Primary care providers' knowledge, beliefs and treatment practices for gout: results of a physician questionnaire
- (2013) L. R. Harrold et al. RHEUMATOLOGY
- Treatment of Acute Gouty Arthritis in Complex Hospitalized Patients With Anakinra
- (2013) Pradipta Ghosh et al. ARTHRITIS CARE & RESEARCH
- Efficacy of anakinra in gouty arthritis: a retrospective study of 40 cases
- (2013) Sébastien Ottaviani et al. ARTHRITIS RESEARCH & THERAPY
- Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator
- (2013) Robert A Terkeltaub et al. ARTHRITIS RESEARCH & THERAPY
- Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy
- (2013) Herbert SB Baraf et al. ARTHRITIS RESEARCH & THERAPY
- Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR)
- (2013) Carlo Scirè et al. ARTHRITIS RESEARCH & THERAPY
- Uric Acid as a Target of Therapy in CKD
- (2012) Diana I. Jalal et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Initiation of Allopurinol at First Medical Contact for Acute Attacks of Gout: A Randomized Clinical Trial
- (2012) Thomas H. Taylor et al. AMERICAN JOURNAL OF MEDICINE
- Comorbidities of Gout and Hyperuricemia in the US General Population: NHANES 2007-2008
- (2012) Yanyan Zhu et al. AMERICAN JOURNAL OF MEDICINE
- Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions
- (2012) Naomi Schlesinger et al. ANNALS OF THE RHEUMATIC DISEASES
- Epidemiology of gout and hyperuricaemia in Italy during the years 2005–2009: a nationwide population-based study
- (2012) Gianluca Trifirò et al. ANNALS OF THE RHEUMATIC DISEASES
- Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof-of-concept randomised controlled trial
- (2012) Nicola Dalbeth et al. ANNALS OF THE RHEUMATIC DISEASES
- Patient and provider barriers to effective management of gout in general practice: a qualitative study: Figure 1
- (2012) Karen Spencer et al. ANNALS OF THE RHEUMATIC DISEASES
- Gout: why is this curable disease so seldom cured?
- (2012) Michael Doherty et al. ANNALS OF THE RHEUMATIC DISEASES
- Purine-rich foods intake and recurrent gout attacks
- (2012) Yuqing Zhang et al. ANNALS OF THE RHEUMATIC DISEASES
- Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study
- (2012) Frances Rees et al. ANNALS OF THE RHEUMATIC DISEASES
- Cherry consumption and decreased risk of recurrent gout attacks
- (2012) Yuqing Zhang et al. ARTHRITIS AND RHEUMATISM
- Rilonacept (Interleukin-1 Trap) in the prevention of acute gout flares during initiation of urate-lowering therapy: Results of a phase II randomized, double-blind, placebo-controlled trial
- (2012) H. Ralph Schumacher et al. ARTHRITIS AND RHEUMATISM
- Starting dose is a risk factor for allopurinol hypersensitivity syndrome: A proposed safe starting dose of allopurinol
- (2012) Lisa K. Stamp et al. ARTHRITIS AND RHEUMATISM
- The pharmacokinetics of oxypurinol in people with gout
- (2012) Sophie L. Stocker et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Canakinumab in gout
- (2012) Naomi Schlesinger EXPERT OPINION ON BIOLOGICAL THERAPY
- Atorvastatin therapy reduces serum uric acid levels: A meta-analysis of randomized controlled trials
- (2012) Hisato Takagi et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Effect of Allopurinol on Blood Pressure: A Systematic Review and Meta-Analysis
- (2012) Vikram Agarwal et al. Journal of Clinical Hypertension
- Efficacy and Tolerability of Celecoxib in the Treatment of Acute Gouty Arthritis: A Randomized Controlled Trial
- (2012) H. R. SCHUMACHER et al. JOURNAL OF RHEUMATOLOGY
- Debulking the Urate Load to Feel Better
- (2012) PASCAL RICHETTE JOURNAL OF RHEUMATOLOGY
- Febuxostat Hypersensitivity
- (2012) A. M. ABELES JOURNAL OF RHEUMATOLOGY
- Improved Health-related Quality of Life and Physical Function in Patients with Refractory Chronic Gout Following Treatment with Pegloticase: Evidence from Phase III Randomized Controlled Trials
- (2012) VIBEKE STRAND et al. JOURNAL OF RHEUMATOLOGY
- Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease
- (2012) Stefan M. Nidorf et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Uric acid as a danger signal in gout and its comorbidities
- (2012) Kenneth L. Rock et al. Nature Reviews Rheumatology
- The Association of Dietary Intake of Purine-Rich Vegetables, Sugar-Sweetened Beverages and Dairy with Plasma Urate, in a Cross-Sectional Study
- (2012) Lina Zgaga et al. PLoS One
- Reduced Glomerular Function and Prevalence of Gout: NHANES 2009–10
- (2012) Eswar Krishnan PLoS One
- Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: Results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study
- (2012) H. Ralph Schumacher et al. ARTHRITIS CARE & RESEARCH
- 2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis
- (2012) Dinesh Khanna et al. ARTHRITIS CARE & RESEARCH
- 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia
- (2012) Dinesh Khanna et al. ARTHRITIS CARE & RESEARCH
- Severe Cutaneous Reactions Requiring Hospitalization in Allopurinol Initiators: A Population-Based Cohort Study
- (2012) Seoyoung C. Kim et al. ARTHRITIS CARE & RESEARCH
- Gout and the risk for incident heart failure and systolic dysfunction
- (2012) Eswar Krishnan BMJ Open
- Prevalence of Contraindications and Prescription of Pharmacologic Therapies for Gout
- (2011) Robert T. Keenan et al. AMERICAN JOURNAL OF MEDICINE
- Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study
- (2011) N. Schlesinger et al. ANNALS OF THE RHEUMATIC DISEASES
- Novel evidence-based colchicine dose-reduction algorithm to predict and prevent colchicine toxicity in the presence of cytochrome P450 3A4/P-glycoprotein inhibitors
- (2011) Robert A. Terkeltaub et al. ARTHRITIS AND RHEUMATISM
- A two-stage approach to the treatment of hyperuricemia in gout: The “dirty dish” hypothesis
- (2011) Fernando Perez-Ruiz et al. ARTHRITIS AND RHEUMATISM
- Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008
- (2011) Yanyan Zhu et al. ARTHRITIS AND RHEUMATISM
- Allopurinol as a Cardiovascular Drug
- (2011) Anita Kelkar et al. Cardiology in Review
- Xanthine Oxidase Inhibition For The Treatment Of Cardiovascular Disease: A Systematic Review and Meta-Analysis
- (2011) Peter Higgins et al. Cardiovascular Therapeutics
- Effect of Prophylaxis on Gout Flares After the Initiation of Urate-Lowering Therapy: Analysis of Data From Three Phase III Trials
- (2011) Robert L. Wortmann et al. CLINICAL THERAPEUTICS
- Efficacy and Tolerability of Pegloticase for the Treatment of Chronic Gout in Patients Refractory to Conventional Treatment
- (2011) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Treatment adherence in patients with gout
- (2011) Gérard Reach JOINT BONE SPINE
- Pharmacokinetic and Pharmacodynamic Interaction Between Allopurinol and Probenecid in Patients with Gout
- (2011) SOPHIE L. STOCKER et al. JOURNAL OF RHEUMATOLOGY
- Safety and Efficacy of Febuxostat Treatment in Subjects with Gout and Severe Allopurinol Adverse Reactions
- (2011) S. CHOHAN JOURNAL OF RHEUMATOLOGY
- Efficacy of Benzbromarone in Hyperuricemic Patients Associated with Chronic Kidney Disease
- (2011) S. Fujimori et al. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- Frequency and risk factors of gout flares in a large population-based cohort of incident gout
- (2011) D. Rothenbacher et al. RHEUMATOLOGY
- Gout. Epidemiology of gout
- (2011) Edward Roddy et al. ARTHRITIS RESEARCH & THERAPY
- Coffee consumption and risk of incident gout in women: the Nurses’ Health Study
- (2010) Hyon K. Choi et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Independent impact of gout on the risk of acute myocardial infarction among elderly women: a population-based study
- (2010) M. A. De Vera et al. ANNALS OF THE RHEUMATIC DISEASES
- Acute effect of milk on serum urate concentrations: a randomised controlled crossover trial
- (2010) N. Dalbeth et al. ANNALS OF THE RHEUMATIC DISEASES
- Gout, Allopurinol Use, and Heart Failure Outcomes
- (2010) George Thanassoulis ARCHIVES OF INTERNAL MEDICINE
- Epidemiology of gout in women: Fifty-two-year followup of a prospective cohort
- (2010) Vidula Bhole et al. ARTHRITIS AND RHEUMATISM
- High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study
- (2010) Robert A. Terkeltaub et al. ARTHRITIS AND RHEUMATISM
- Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment
- (2010) Lisa K. Stamp et al. ARTHRITIS AND RHEUMATISM
- Colchicine poisoning: the dark side of an ancient drug
- (2010) Yaron Finkelstein et al. CLINICAL TOXICOLOGY
- Gout and hyperuricemia in young people
- (2010) Hisashi Yamanaka CURRENT OPINION IN RHEUMATOLOGY
- Colchicine for the treatment of gout
- (2010) Pascal Richette et al. EXPERT OPINION ON PHARMACOTHERAPY
- Fructose-Rich Beverages and Risk of Gout in Women
- (2010) Hyon K. Choi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Uric acid transport and disease
- (2010) Alexander So et al. JOURNAL OF CLINICAL INVESTIGATION
- Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial
- (2010) Awsan Noman et al. LANCET
- Effects of Three Strong Statins (Atorvastatin, Pitavastatin, and Rosuvastatin) on Serum Uric Acid Levels in Dyslipidemic Patients
- (2010) N. Ogata et al. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- The serum urate-lowering impact of weight loss among men with a high cardiovascular risk profile: the Multiple Risk Factor Intervention Trial
- (2010) Y. Zhu et al. RHEUMATOLOGY
- Anakinra's Efficacy is Variable in Refractory Gout: Report of Ten Cases
- (2010) Kun Chen et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
- (2010) Michael A Becker et al. ARTHRITIS RESEARCH & THERAPY
- Plasma Urate and Parkinson's Disease in the Atherosclerosis Risk in Communities (ARIC) Study
- (2009) H. Chen et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study
- (2009) R Terkeltaub et al. ANNALS OF THE RHEUMATIC DISEASES
- Quality of Life and Disability in Patients with Treatment-Failure Gout
- (2009) M. A. BECKER et al. JOURNAL OF RHEUMATOLOGY
- Frequency, Risk, and Cost of Gout-related Episodes Among the Elderly: Does Serum Uric Acid Level Matter?
- (2009) E. Q. WU et al. JOURNAL OF RHEUMATOLOGY
- Adherence with urate-lowering therapies for the treatment of gout
- (2009) Leslie R Harrold et al. ARTHRITIS RESEARCH & THERAPY
- A critical reappraisal of allopurinol dosing, safety, and efficacy for hyperuricemia in gout
- (2009) Jeannie Chao et al. Current Rheumatology Reports
- Effect of Fenofibrate on Kidney Function: A 6-Week Randomized Crossover Trial in Healthy People
- (2008) Jean-Claude Ansquer et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout
- (2008) M K Reinders et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol
- (2008) M K Reinders et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term Cardiovascular Mortality Among Middle-aged Men With Gout
- (2008) Eswar Krishnan ARCHIVES OF INTERNAL MEDICINE
- Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: Results of a phase II randomized study
- (2008) John S. Sundy et al. ARTHRITIS AND RHEUMATISM
- Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: A 28-week, phase III, randomized, double-blind, parallel-group trial
- (2008) H. RALPH Schumacher et al. ARTHRITIS AND RHEUMATISM
- Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial
- (2008) Hein JEM Janssens et al. LANCET
- Uric Acid and Cardiovascular Risk
- (2008) Daniel I. Feig et al. NEW ENGLAND JOURNAL OF MEDICINE
- Determinants of the Clinical Outcomes of Gout During the First Year of Urate-Lowering Therapy
- (2008) Michael A. Becker et al. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- A European study of HLA-B in Stevens???Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs
- (2008) Christine Lonjou et al. Pharmacogenetics and Genomics
- Colchicine Update: 2008
- (2008) Robert A. Terkeltaub SEMINARS IN ARTHRITIS AND RHEUMATISM
- Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel
- (2007) Sima Halevy et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started